ClinicalTrials.gg
CompletedNCT05207917BaSESUpdated Sep 22, 2026

How Does Bariatric Surgery Affect Social Experiences and Well-being - The BaSES-study

An interventional study of Gastric bypass and Sleeve gastrectomy in Obesity, sponsored by The Hospital of Vestfold. Completed at 1 site in Norway. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by The Hospital of Vestfold · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
134
Allocation
Non-randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 116 studies in Obesity with a site in Norway — 3 open to participants now, 13 under way, 1 of them phase 3. Obesity · Norway.

Enrollment
26th of 103
134 · median 64
Started
2022
with 4 others
No phase
86 of 116
2 open now
Registered
101st of 116
by date
Lead sponsor
3 of 116
The Hospital of Vestfold

Among the 116 studies in Obesity with a site in Norway, this one is the 26th largest by enrollment of the 103 interventional ones that give a count, is one of 5 that started in 2022, is one of 86 with no phase, and was the 101st registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

3 of the 116 studies in Obesity with a site in Norway are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 116 studies in Obesity with a site in Norway, or all of them as a file.
02

Study summary

Nonrandomized controlled trial to assess whether or not sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) affect social experiences and biomarkers of well-being 6 weeks and 1 year after surgery. The decision whether SG or RYGB will be performed is determined by medical decision making. Hypotheses: Bariatric surgery influences social experiences and well-being through changes in body image, reward responsivity and gut hormones. These changes may differ between gastric bypass (RYGB) and sleeve gastrectomy (SG).

Read the detailed description

Explanation for choice of comparators

Obesity is one of the world's most serious public health problems. Conservative weight reduction methods alone (diet, exercise) often show disappointing results, as the majority of people who lose weight regain it after a shorter or longer period of time. The currently most effective measure to achieve a durable weight-loss is bariatric surgery.

When investigating the effectiveness of bariatric surgery, the focus has most often been on weight loss and obesity-related complications, while effects on social interaction and subjective experience have received much less attention. A large body of evidence has demonstrated that (supportive) social relationships benefit health. Individuals with low compared to those with high levels of social connectedness are more likely to die prematurely; and social relationships can also affect a range of other health conditions such as cardiovascular disease, cancer, and immune function. Importantly, individuals with obesity may experience social interactions as less positive than normal-weight individuals. They recount avoiding social events and relationships, but also career opportunities, shopping and other activities where they feel observed because of weight stigma. Such avoidance behavior can lead to a "chronic disengagement" with many aspects of social life, which in turn might decrease interpersonal skills. Further investigations into the link between social behavior and eating found that greater emotional eating is associated with greater social avoidance. Eating was described a means to cope with loneliness on the one hand, while on the other hand aggravating feelings of being alone due to the stigma associated with obesity. This way, loneliness and obesity can create a vicious circle. In terms of how bariatric surgery influences social interactions, one 10-year follow up study found improvements in social interactions for bariatric surgery, but not for conventional weight loss treatment. In qualitative studies, many participants mentioned that they received more positive social feedback following bariatric surgery, and that they enjoyed social activities more than before, although they also describe ambiguous feelings.

The present study will investigate whether and how two types of bariatric surgery improve the response to a range of social aspects of patients' daily lives. Further, it aims to determine potential mechanisms leading to these effects, namely changes in body image, gut hormones, and reward responsivity.

03

Conditions studied

  • Obesity

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • scheduled for bariatric surgery and eligible for sleeve gastrectomy or gastric bypass
  • able to give consent
  • understand written and spoken Norwegian

Exclusion criteria

Exclusion Criteria:

  • pregnancy and breast-feeding
  • chronic disease (endocrine, heart, neurological, lung, gastrointestinal, kidney)
  • cancer
  • acute psychotic episode
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
134 participants (actual)

Study arms

  • Active comparator
    Gastric bypass

    Gastric bypass

    Procedure: Gastric bypass

  • Active comparator
    Sleeve gastrectomy

    Sleeve gastrectomy

    Procedure: Sleeve gastrectomy

  • Experimental
    Single anastomosis sleeve ileal (SASI) bypass

    Exploratory small arm with a small number of particpants

    Procedure: Single anastomosis sleeve ileal (SASI) bypass

Interventions

  • ProcedureGastric bypass

    In Roux-en-Y gastric bypass (RYGB), the left crus will be dissected free, any hiatal hernia left in place. The minor curvature is opened at the second vessel and the lesser sac entered. A 25 mL gastric pouch will be created by firing one horizontal and two vertical staple loads. The ligament of Treitz is then identified and a proximal loop of small intestine anastomosed to the pouch 60 cm from the ligament of Treitz with one linear stapler (full length of the stapler), creating an antecolic, antegastric alimentary limb. The opening will be closed using a single row, running absorbable suture. An entero-enteroanastomosis will be made 120 cm distal of the gastro-enteroanastomosis. The introductory opening is closed with a single row, running absorbable suture. The small intestine will be divided with one load between the gastro-entero-enteroanastomosis and the entero-enteroanastomosis in order to complete a bypass with an alimentary limb of 120 cm and a biliopancreatic limb of 60 cm.

  • ProcedureSleeve gastrectomy

    In sleeve gastrectomy (SG) a large part (80%) of the ventricle is removed. The greater curvature will be dissected free starting 4-5 cm from the pylorus up to the angle of Hiss. The left crus is then visualized and inspected for hiatal hernia. Small sliding hernias and wide hiatus are left in situ. The ventricle will then be lifted and any adhesions in the lesser sac divided. A 35 Fr bougie is placed down to the pylorus guiding the creation of a tubular sleeve with linear staplers. The first two loads are always green or purple, while blue or tan loads are used for the rest of the ventricle. The last stapler is placed 5 mm laterally to the angle of Hiss. The staple line will then be inspected and secured with clips for additional haemostasis, no oversewing or buttressing material is routinely used.

  • ProcedureSingle anastomosis sleeve ileal (SASI) bypass

    The SASI bypass will performed with a similar entry of the abdominal cavity. A 6-port set up and a liver retractor is utilized. The small bowel is measured 300cm from the ileocecal valve, in sequences of 10cm, with the small bowel stretched and markers placed on the graspers, and connected to the antrum of the stomach with a 45mm stapler. The anastomosis is positioned slightly ventral on the antrum. The antrum is opened ventrally 5 cm proximal to the pylorus, just below the horizontal axis of canalis pylori. A 12 mm port positioned left to the midline is used for introduction of the stapler, which is directed distally from the patient's left to right side. 2.5 cm of the 45 mm stapler device is used for firing the anastomosis, which is completed with a 2-0 PDS running suture. The fascia defect is closed for the port where the specimen is extracted. The mesenteric defect is not closed.

06

What researchers measure

Primary outcomes

  1. 1-year changes in Social Experience

    10-item checklist assessing frequency and quality of daily social interactions (preprint in August 2025: https://osf.io/preprints/psyarxiv/6psar\_v2); 2 sub-scales: (1) Being with others, (2) Being alone; the diary will be filled in 14 days in a row at the end of the day. Scale (1) was designed to measure enjoyment of being with others and the duration of social contact (6 items, range: 4 to 62.4), higher values indicate more enjoyment and a higher frequency of social contact. Scale (2) was designed to measure enjoyment of being alone (3 items, range: -5 to 20), higher values here indicate more enjoyment of being alone. An additional item at the beginning of the checklists asks how many people the respondent has had social contact with during the day (5 categories).

    Time frame: Change from 4 weeks before surgery to 1 year after surgery

Secondary outcomes

  1. Changes in affect ratings after social evaluation (inclusion and exclusion)

    Positive and Negative Affect Schedule (PANAS): The PANAS is a self-report measure that is made up of two mood scales of 10 adjectives each, one measuring positive affect and the other one measuring negative affect. (1) Positive Affect Scale (range: 10-50; higher values indicate higher positive affect); (2) Negative Affect Scale (range: 10-50, higher values indicate higher negative affect)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  2. Changes in experience ratings after social evaluation (inclusion and exclusion)

    Need-Threat Scale: 4 sub-scales: (1) Belonging, (2) Self-Esteem, (3) Meaningful existence, (4) Control; range: 3-27 per sub-scale; higher values indicate more belonging, higher self-esteem, higher meaningful existence, and more control)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  3. Changes in pleasantness ratings in response to touch stimulation on the forearm

    Subjective ratings on a digitally presented visual analogue scale (VAS) scale: range 0-100 (unpleasant - pleasant) after a touch stimulation to the forearm (repeated 10 times)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  4. Changes in pleasantness ratings in response to self-stroking on the forearm

    Subjective ratings on a digitally presented VAS scale: range 0-100 (unpleasant - pleasant), after participants made 10 back-and-forth strokes on their forearm with their hand

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  5. Changes in intensity ratings in response to touch stimulation on the forearm

    Subjective ratings on a digitally presented VAS scale: range 0-100 (not intense - intense), after a touch stimulation to the forearm (repeated 10 times)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  6. Changes in intensity ratings in response to self-stroking on the forearm

    Subjective ratings on a digitally presented VAS scale: range 0-100 (not intense - intense), after participants made 10 back-and-forth strokes on their forearm with their hand

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  7. Changes in self-stroking velocity

    Participants are instructed to stroke their own forearm with a velocity they experience as pleasant. The duration of 10 back-and-forth strokes over a 10 cm distance on the forearm will be measured with a stop watch. Velocity in cm/sec will be calculated thereafter.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  8. Changes in cortisol levels from hair samples

    Cortisol (in pg/mg)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  9. Changes in endocannabinoid levels from hair samples

    Endocannabinoids (in pg/mg)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  10. Changes in fasting ghrelin levels from blood samples

    Ghrelin (in pg/ml)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  11. Changes in body image

    Questionnaires: Appearance Evaluation Scale (AES) and the Body Areas Satisfaction Scale (BASS) - the AES was designed to measure overall satisfaction/dissatisfaction with one's appearance and physical attractiveness. It has 7 items (range: 5-35) with high scores indicating body satisfaction and low scores indicating body dissatisfaction. The BASS was designed to measure the degree of dissatisfaction-satisfaction with specific body areas and attributes (range: 9-45). Higher scores indicate greater body satisfaction and lower scores indicate greater body dissatisfaction.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  12. Changes in reward responsivity

    Questionnaire: Temporal Experience of Pleasure Scale (TEPS) - the TEPS was designed to measure individual trait dispositions in both anticipatory and consummatory experiences of pleasure. It consists of 18 items, of which 10 form the (1) anticipatory pleasure scale (range: 10-60), and (2) 8 items for the consummatory pleasure scale (range: 8-48). Higher values on (1) indicate enhanced reward responsiveness and imagery, while higher values on (2) indicate higher openness to different experiences and appreciation of positive stimuli.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  13. Changes in interoceptive ability

    Questionnaire: Body Awareness Questionnaire (BAQ) - the BAQ was designed to assess self-reported attentiveness to normal nonemotive body processes, such as sensitivity to body rhythms, ability to detect small changes in normal bodily functioning, and one's ability to anticipate bodily reactions. It consists of 18 items (range: 18-126). Higher values indicate a higher sensitivity and awareness of one's bodily states.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  14. Changes in belongingness

    Questionnaires: The Social Connectedness Scale Revised (SCS-R) and the Social Assurance Scale (SAS). The SCS-R was designed to measure a psychological sense of belonging, or how individuals cognitively construe interpersonal closeness with others in their social world. It consists of 20 items (range: 20-120), with higher values indicating a higher sense of belonging. The SAS was designed to measure the importance of assurance from one's social group.It consists of 8 items (range: 8-48), with higher values indicating a higher need for social assurance.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  15. Changes in social network size

    Questionnaire: The Social Network Index (SNI) - the SNI was designed to measure three aspects of one's social networks: (1) network diversity, (2) number of people in the network, and (3) number of embedded networks. Each of the three sub-scales is assessed on 12 items. (1) refers to the number of high-contact roles (range: 0-12), with higher values indicating a higher number of social roles. (2) refers to the total number of people with whom the respondent has regular contact, which will be summed for the 12 items (range: 0-70). Higher numbers indicate more people in one's network (to not inflate the number, items 4-12 will be scored with 7 in case the reported number of people in this group is equivalent or larger to 7). The embedded network scale (3) reflects the number of different network domains in which a respondent is active (range: 0-8), with higher numbers indicating activity in more network domains.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  16. Changes in self-reported eating patterns

    Questionnaire:The Three Factor Eating Questionnaire -R 21 (TFEQ-R21) measures eating behaviour and has been validated for use in individuals with obesity and will be used in the study. It consists of 21 items comprising three domain scores; (1) uncontrolled eating; assessing the tendency to lose control over eating when feeling hungry or when exposed to external stimuli, (2) cognitive restraint; assessing the conscious restriction of food intake to control body weight or body shape, and (3) emotional eating; assessing overeating related to negative mood states. The domain scores were transformed to 0-100 scales to facilitate comparison; a higher score indicates more uncontrolled, restraint, or emotional eating.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  17. Changes in symptoms of depression and anxiety

    Questionnaire: Hospital Anxiety and Depression Scale (HADS). The validated generic HADS measures symptoms of anxiety and depression using 14 items scored from 0-3 It is decomposed into two domains measuring depression (HADS-D) and anxiety (HADS-A), both consisting of seven items yielding a score from 0-21.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  18. Changes in Health Related Quality of Life 1

    Generic questionnaire: Short Form-36 Health Survey (SF-36). Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores for each of the 8 domains and summary scores for physical and mental health will be calculated.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  19. Changes in Health Related Quality of Life 2

    Questionnaire: Weight-related Symptom Measure (WRSM). The validated obesity specific WRSM measures 20 symptoms commonly related to being overweight or obese, including foot problems, joint pain, sensitivity to cold, shortness of breath, etc. using two different sets of items. The first set assesses whether or not a patient is experiencing specific symptoms, and the second set rates the level of the distress of the symptoms with values from zero ("not at all") to six ("bothers a very great deal"). The first set creates an additive scale summing symptoms from 0-20, while the second forms a symptom distress scale ranging from 0-120.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  20. Changes in Health Related Quality of Life 3

    Obesity specific questionnaire: The Impact of Weight on Quality of Life-Lite (IWQOL-lite). The IWQOL-Lite is a 31-item measure of weight-related quality of life. There are five domain scores (Physical Function, Self-Esteem, Sexual Life, Public Distress and Work) and a total score. Scores for all domains and total score range from 0-100, with lower scores indicating greater impairment.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  21. 6-week Changes in Social Experience

    10-item checklist assessing frequency and quality of daily social interactions (preprint in August 2025: https://osf.io/preprints/psyarxiv/6psar\_v2); 2 sub-scales: (1) Being with others, (2) Being alone; the diary will be filled in 14 days in a row at the end of the day. Scale (1) was designed to measure enjoyment of being with others and the duration of social contact (6 items, range: 4 to 62.4), higher values indicate more enjoyment and a higher frequency of social contact. Scale (2) was designed to measure enjoyment of being alone (3 items, range: -5 to 20), higher values here indicate more enjoyment of being alone. An additional item at the beginning of the checklists asks how many people the respondent has had social contact with during the day (5 categories).

    Time frame: Change from 4 weeks before surgery to 6 weeks after surgery

  22. Group differences between SG and RYBG patients in the above-mentioned outcomes [1-22]

    The above-mentioned outcomes will be tested for differences between the two surgery types.

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

Other outcomes

  1. Change in Body Mass Index (BMI)

    calculated from height (in cm) and weight (in kg) as kg/m\^2

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  2. Change in weight

    Percent total weight loss (%TWL) and in kg

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  3. Change in anthropometric measures

    Waist and hip circumference (cm)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  4. Change in body fat

    Body fat (in %)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  5. Change in fat-free mass

    Fat-free mass (in kg)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  6. Change in blood pressure

    Systolic and diastolic blood pressure (mm/Hg)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  7. Change in lipids

    Total-cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (all in mmol/l)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  8. Change in glucose parameters

    HbA1c (mmol/mol); C-peptide (nmol/l)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  9. Change in C-reactive protein (CRP)

    CRP (mg/L)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  10. Change in blood enzymes

    ASAT (aspartate aminotransferase), ALAT (alanine-aminotransferase), LD (lactate dehydrogenase), Gamma-GT (gamma-glutamyl transferase), ALP (alkaline phosphatase) (all in U/L)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  11. Change in hemoglobin

    Hemoglobin (g/100 ml)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

  12. Change in ferritin

    Ferritin ((µg/L)

    Time frame: Change from 4 weeks before surgery to 6 weeks and 1 year after surgery

07

Study locations

1 site
  • Morbid Obesity Center
    Tønsberg, Vestfold 3103, Norway
08

References and documents

Publications

  • Broadhead WE, Kaplan BH, James SA, Wagner EH, Schoenbach VJ, Grimson R, Heyden S, Tibblin G, Gehlbach SH. The epidemiologic evidence for a relationship between social support and health. Am J Epidemiol. 1983 May;117(5):521-37. doi: 10.1093/oxfordjournals.aje.a113575. No abstract available. PubMed 6342368 ↗
  • Uchino BN. Social support and health: a review of physiological processes potentially underlying links to disease outcomes. J Behav Med. 2006 Aug;29(4):377-87. doi: 10.1007/s10865-006-9056-5. Epub 2006 Jun 7. PubMed 16758315 ↗
  • Umberson D, Montez JK. Social relationships and health: a flashpoint for health policy. J Health Soc Behav. 2010;51 Suppl(Suppl):S54-66. doi: 10.1177/0022146510383501. PubMed 20943583 ↗
  • Maphis LE, Martz DM, Bergman SS, Curtin LA, Webb RM. Body size dissatisfaction and avoidance behavior: how gender, age, ethnicity, and relative clothing size predict what some won't try. Body Image. 2013 Jun;10(3):361-8. doi: 10.1016/j.bodyim.2013.02.003. Epub 2013 Mar 27. PubMed 23540887 ↗
  • Brytek-Matera A, Czepczor-Bernat K, Olejniczak D. Food-related behaviours among individuals with overweight/obesity and normal body weight. Nutr J. 2018 Oct 16;17(1):93. doi: 10.1186/s12937-018-0401-7. PubMed 30326901 ↗
  • Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond). 2007 Aug;31(8):1248-61. doi: 10.1038/sj.ijo.0803573. Epub 2007 Mar 13. PubMed 17356530 ↗
  • Coulman KD, MacKichan F, Blazeby JM, Owen-Smith A. Patient experiences of outcomes of bariatric surgery: a systematic review and qualitative synthesis. Obes Rev. 2017 May;18(5):547-559. doi: 10.1111/obr.12518. Epub 2017 Mar 8. PubMed 28273694 ↗
  • Pfabigan DM, Hertel JK, Svanevik M, Lindberg M, Sailer U, Hjelmesaeth J. Single-centre, non-randomised clinical trial at a tertiary care centre to investigate 1-year changes in social experiences and biomarkers of well-being after bariatric surgery in individuals with severe obesity: protocol for the Bariatric Surgery and Social Experiences (BaSES) study. BMJ Open. 2023 Aug 28;13(8):e071332. doi: 10.1136/bmjopen-2022-071332. PubMed 37640458 ↗

Individual participant data

Plan to share: Yes — De-anonymized individual participant data can be made available following publication upon reasonable request to authors Jøran Hjelmesæth and Uta Sailer. Data will be shared according to the consent given by the participants and Norwegian laws and legislation.

Time frame: For at least 10 years after publication

Access criteria: All requests must be handled within the legal framework of Norway; non-commercial use of de-anonymized data

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2022 to primary completion in Nov 2025, 41 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 41 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2021
First posted
Jan 26, 2022
StartActual
May 12, 2022
Primary completionActual
Nov 5, 2025
CompletionActual
Nov 5, 2025
Last update
Sep 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05207917
Lead sponsor
The Hospital of Vestfold
Collaborators
University of Oslo
Responsible party
Jøran Hjelmesæth (Professor, The Hospital of Vestfold) — Principal investigator
First posted
Jan 26, 2022
Start date
May 12, 2022
Primary completion
Nov 5, 2025
Completion
Nov 5, 2025
Last update
Sep 22, 2026

Study contacts

Jøran Hjelmesæth, Professor
principal investigator · The Hospital of Vestfold

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion